- Losers: Leap Therapeutics (NASDAQ:LPTX) +49%.
- Yuma Energy (NYSEMKT:YUMA) +31%.
- Inpixon (NASDAQ:INPX) +25%.
- BioXcel Therapeutics (NASDAQ:BTAI) +23%.
- Nymox Pharmaceutical (NASDAQ:NYMX) +21%.
- Acorda Therapeutics (NASDAQ:ACOR) +19%.
- LAIX (NYSE:LAIX) +18%.
- Camber Energy (NYSEMKT:CEI) +18%.
- Pacific Drilling (NYSE:PACD) +17%.
- Ocular Therapeutix (NASDAQ:OCUL) +15%.
- Losers: Novan (NASDAQ:NOVN) -73%.
- DPW Holdings (NYSEMKT:DPW) -27%.
- Synthesis Energy Systems (NASDAQ:SES) -18%.
- Trillium Therapeutics (NASDAQ:TRIL) -17%.
- TuanChe (NASDAQ:TC) -12%.
- Landec (NASDAQ:LNDC) -12%.
- Bat Group (NASDAQ:GLG) -11%.
- Incyte (NASDAQ:INCY) -10%.
- Viveve Medical (NASDAQ:VIVE) -10%.
- Mereo BioPharma (NASDAQ:MREO) -9%.